Latest Mitral valve annuloplasty Stories
Funds to Be Used to Extend Commercial Efforts, Capitalize on Promising Patient Data KIRKLAND, Wash., Oct.
Third Multi-Center Study Shows Compelling Results Consistent with Previous Trials; Data Presented at TCT KIRKLAND, Wash., Sept. 17, 2014 /PRNewswire/ -- Cardiac Dimensions(®), Inc.
- Medicare will Provide National Coverage for People with Severe Degenerative Mitral Regurgitation Deemed Too Sick for Surgery ABBOTT PARK, Ill., Aug.
Comprehensive study “European Market for Cardiac Surgery Devices 2014” worked out by iData Research is now available at MarketPublishers.com.
Revolutionizing developments in biological tissue vales will drive the European transcatheter heart valve implantation market to over $1.7 Billion by 2020, Reports iData Research Vancouver,
LONDON, April 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Funding Will Enable Initiation of Blinded, Randomized Clinical Trial and Expanded Commercialization of CARILLON® Mitral Contour System® KIRKLAND, Wash., April 16, 2014 /PRNewswire/
CHICAGO, March 21, 2014 /PRNewswire/ - Allegations continue surrounding the testing of two annuloplasty rings, invented by the chief of cardiac surgery, Dr.
Sets Stage for Expanded Adoption Of CARILLON® Mitral Contour System® KIRKLAND, Wash., Feb. 19, 2014 /PRNewswire/ -- Cardiac Dimensions(®),( )Inc.
The Washington University and Barnes-Jewish Heart & Vascular Center was one of 47 centers nationwide to participate in the medical trial that led to approval of the device by the FDA.
- Having a loud voice; vociferous; clamorous.
- Of grand or imposing sound.